192 related articles for article (PubMed ID: 37366903)
1. Factors Associated with Long-Term Prostate Cancer Survival after Palliative Radiotherapy to a Bone Metastasis and Contemporary Palliative Systemic Therapy: A Retrospective, Population-Based Study.
Venugopal B; Shahhat S; Beck J; Hanumanthappa N; Ong AD; Dubey A; Koul R; Bashir B; Chowdhury A; Sivananthan G; Kim JO
Curr Oncol; 2023 Jun; 30(6):5560-5573. PubMed ID: 37366903
[TBL] [Abstract][Full Text] [Related]
2. Utilization of palliative radiotherapy for bone metastases near end of life in a population-based cohort.
Tiwana MS; Barnes M; Kiraly A; Olson RA
BMC Palliat Care; 2016 Jan; 15():2. PubMed ID: 26748495
[TBL] [Abstract][Full Text] [Related]
3. Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital-based analysis of patterns of care, RT fractionation scheme, and overall survival.
Fischer-Valuck BW; Baumann BC; Apicelli A; Rao YJ; Roach M; Daly M; Dans MC; White P; Contreras J; Henke L; Gay H; Michalski JM; Abraham C
Cancer Med; 2018 Sep; 7(9):4240-4250. PubMed ID: 30120817
[TBL] [Abstract][Full Text] [Related]
4. Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.
Francini E; Montagnani F; Nuzzo PV; Gonzalez-Velez M; Alimohamed NS; Rosellini P; Moreno-Candilejo I; Cigliola A; Rubio-Perez J; Crivelli F; Shaw GK; Zhang L; Petrioli R; Bengala C; Francini G; Garcia-Foncillas J; Sweeney CJ; Higano CS; Bryce AH; Harshman LC; Lee-Ying R; Heng DYC
JAMA Netw Open; 2021 Jul; 4(7):e2116536. PubMed ID: 34292336
[TBL] [Abstract][Full Text] [Related]
5. Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Ali A; Hoyle A; Haran ÁM; Brawley CD; Cook A; Amos C; Calvert J; Douis H; Mason MD; Dearnaley D; Attard G; Gillessen S; Parmar MKB; Parker CC; Sydes MR; James ND; Clarke NW
JAMA Oncol; 2021 Apr; 7(4):555-563. PubMed ID: 33599706
[TBL] [Abstract][Full Text] [Related]
6. Impact of a dedicated palliative radiation oncology service on the use of single fraction and hypofractionated radiation therapy among patients with bone metastases.
Skamene S; Agarwal I; Makar M; Krishnan M; Spektor A; Hertan L; Mouw KW; Taylor A; Noveroske Philbrick S; Balboni T
Ann Palliat Med; 2018 Apr; 7(2):186-191. PubMed ID: 29307209
[TBL] [Abstract][Full Text] [Related]
7. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
Brundage MD; Crook JM; Lukka H
Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
[TBL] [Abstract][Full Text] [Related]
8. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
9. The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE's "M1|RT Comparison".
Ali A; Hoyle AP; Parker CC; Brawley CD; Cook A; Amos C; Calvert J; Douis H; Mason MD; Attard G; Parmar MKB; Sydes MR; James ND; Clarke NW;
Eur Urol Oncol; 2020 Aug; 3(4):412-419. PubMed ID: 32591246
[TBL] [Abstract][Full Text] [Related]
10. How many bone metastases may be defined as high-volume metastatic prostate cancer in Asians: A retrospective multicenter cohort study.
Yamada Y; Sakamoto S; Rii J; Yamamoto S; Kamada S; Imamura Y; Nakamura K; Komiya A; Nakatsu H; Ichikawa T
Prostate; 2020 Apr; 80(5):432-440. PubMed ID: 32017175
[TBL] [Abstract][Full Text] [Related]
11. Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study.
Chen AB; Cronin A; Weeks JC; Chrischilles EA; Malin J; Hayman JA; Schrag D
J Clin Oncol; 2013 Feb; 31(5):558-64. PubMed ID: 23295799
[TBL] [Abstract][Full Text] [Related]
12. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
13. Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer.
Hess G; Barlev A; Chung K; Hill JW; Fonseca E
Radiat Oncol; 2012 Oct; 7():168. PubMed ID: 23062178
[TBL] [Abstract][Full Text] [Related]
14. Do Coordinated Knowledge Translation Campaigns Persuade Radiation Oncologists to Use Single-Fraction Radiation Therapy Compared With Multiple-Fraction Radiation Therapy for Bone Metastases?
Shahhat S; Hanumanthappa N; Chung YT; Beck J; Koul R; Bashir Bashir ; Cooke A; Dubey A; Butler J; Nashed M; Hunter W; Rathod S; Ong A; Tran K; Kim JO
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):365-373. PubMed ID: 32890661
[TBL] [Abstract][Full Text] [Related]
15. Patterns of practice in palliative radiotherapy for painful bone metastases: impact of a regional rapid access clinic on access to care.
Wu JS; Kerba M; Wong RK; Mckimmon E; Eigl B; Hagen NA
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):533-8. PubMed ID: 19910133
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of helical conformal versus nonconformal palliative radiation therapy for axial skeletal metastases.
Romano KD; Trifiletti DM; Bauer-Nilsen K; Wages NA; Watkins WT; Read PW; Showalter TN
Pract Radiat Oncol; 2017; 7(6):e479-e487. PubMed ID: 28666907
[TBL] [Abstract][Full Text] [Related]
17. A Population-Based Study of Palliative Radiation Therapy for Bone Metastases in Patients Dying of Prostate Cancer.
Cho CJ; Sunderland K; Pickles T; Bachand F; Chi KN; Tyldesley S
Pract Radiat Oncol; 2019 May; 9(3):e274-e282. PubMed ID: 30641243
[TBL] [Abstract][Full Text] [Related]
18. Patterns of care among patients receiving radiation therapy for bone metastases at a large academic institution.
Ellsworth SG; Alcorn SR; Hales RK; McNutt TR; DeWeese TL; Smith TJ
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1100-1105. PubMed ID: 25035214
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting the use of single-fraction radiotherapy for the palliation of bone metastases in Australia.
Petrushevski AN; Gabriel GS; Hanna TP; Allen S; Allison RW; Barton MB
Clin Oncol (R Coll Radiol); 2015 Apr; 27(4):205-12. PubMed ID: 25533480
[TBL] [Abstract][Full Text] [Related]
20. Changing pattern of radiation therapy for bone metastases in an Australian population-based cohort of men with prostate cancer.
Ong WL; Milne RL; Foroudi F; Millar JL
Clin Genitourin Cancer; 2022 Feb; 20(1):e7-e15. PubMed ID: 34366292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
